Skip to menu Skip to content Skip to footer

2014

Journal Article

Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy

Morais, Christudas, Small, David M., Vesey, David A., Martin, Jennifer, Johnson, David W. and Gobe, Glenda C. (2014). Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy. Biochemical and Biophysical Research Communications, In Press, Corrected Proof (3), 1-6. doi: 10.1016/j.bbrc.2014.01.047

Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy

2014

Journal Article

Chronic kidney disease: Haemodialysis catheter care in practice

Badve, Sunil V. and Johnson, David W. (2014). Chronic kidney disease: Haemodialysis catheter care in practice. Nature Reviews Nephrology, 10 (3), 131-133. doi: 10.1038/nrneph.2014.3

Chronic kidney disease: Haemodialysis catheter care in practice

2014

Journal Article

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients

Cho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Pascoe, Elaine M., Clarke, Margaret, Topley, Nicholas and on behalf of the balANZ Trial Investigators (2014). Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients. BMC Nephrology, 15 (1) 8. doi: 10.1186/1471-2369-15-8

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients

2014

Journal Article

Association between GFR estimated by multiple methods at dialysis commencement and patient survival

Wong M.G., Pollock C.A., Cooper B.A., Branley P., Collins J.F., Craig J.C., Kesselhut J., Luxton G., Pilmore A., Harris D.C. and Johnson D.W. (2014). Association between GFR estimated by multiple methods at dialysis commencement and patient survival. Clinical Journal of the American Society of Nephrology, 9 (1), 135-142. doi: 10.2215/CJN.02310213

Association between GFR estimated by multiple methods at dialysis commencement and patient survival

2014

Journal Article

Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines

Bennett, Nigel C., Hooper, John D., Johnson, David W. and Gobe, Glenda C. (2014). Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines. Prostate, 74 (5), 478-487. doi: 10.1002/pros.22767

Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines

2014

Journal Article

The association between peritoneal dialysis modality and peritonitis

Lan, Patrick G., Johnson, David W., McDonald, Stephen P., Boudville, Neil, Borlace, Monique, Badve, Sunil V., Sud, Kamal and Clayton, Philip A. (2014). The association between peritoneal dialysis modality and peritonitis. Clinical Journal of the American Society of Nephrology, 9 (6), 1091-1097. doi: 10.2215/CJN.09730913

The association between peritoneal dialysis modality and peritonitis

2014

Conference Publication

The effect of pentoxifylline on oxidative stress markers: substudy of the hero trial

Zhang, L., Pascoe, E. M., Badve, S. V., Cass, A., Clarke, P., Coombes, J. S., Ferrari, P., Mcdonald, S. P., Morrish, A. T., Pedagogos, E., Perkovic, V., Reidlinger, D., Scaria, A., Walker, R., Vergara, L. A., Hawley, C. M. and Johnson, D. W. (2014). The effect of pentoxifylline on oxidative stress markers: substudy of the hero trial. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, VIC, Australia, 25-27 August 2014. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301

The effect of pentoxifylline on oxidative stress markers: substudy of the hero trial

2014

Book Chapter

Anaemia: prevalence, risk factors and management with a focus on chronic kidney disease

Abdul Razak, K., Mudge, D. W. and Johnson, D. W. (2014). Anaemia: prevalence, risk factors and management with a focus on chronic kidney disease. Anemia: prevalence, risk factors and management strategies. (pp. 123-146) Hauppauge, NY United States: Nova Science Publishers.

Anaemia: prevalence, risk factors and management with a focus on chronic kidney disease

2014

Journal Article

Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial

Johnson, David W., Badve, Sunil V., Pascoe, Elaine M., Beller, Elaine, Cass, Alan, Clark, Carolyn, de Zoysa, Janak, Isbel, Nicole M., McTaggart, Steven, Morrish, Alicia T., Playford, E. Geoffrey, Scaria, Anish, Snelling, Paul, Vergara, Liza A., Hawley, Carmel M. and for the HONEYPOT Study Collaborative Group (2014). Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial. The Lancet Infectious Diseases, 14 (1), 23-30. doi: 10.1016/S1473-3099(13)70258-5

Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial

2014

Conference Publication

Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum

Rossi, M., Campbell, K. L., Johnson, D. W., Stanton, T., Pascoe, E. M., Hawley, C. M., Dimeski, G., Mcwhinney, B. C., Ungerer, J. P. and Isbel, N. M. (2014). Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. HOBOKEN: Wiley.

Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum

2014

Book Chapter

Erythropoiesis stimulating agent resistance

O'Shea, Stacey, Badve, Sunil V. and Johnson, David W. (2014). Erythropoiesis stimulating agent resistance. Advances in drug resistance research. (pp. 120-135) edited by Christudas Morais. New York, NY, United States: Nova Science Publishers.

Erythropoiesis stimulating agent resistance

2014

Conference Publication

Research priorities in chronic kidney disease: a priority setting partnership

Tong, A., Crowe, S., Chando, S., Cass, A., Chadban, S. J., Chapman, J. R., Gallagher, M., Gillis, J., Hawley, C., Hill, S., Howard, K., Johnson, D. W., Kerr, P., Mathew, T., Mckenzie, A., Parker, D., Polkinghorne, K., Perkovic, V., Pollock, C., Strippoli, G. F. M., Tugwell, P., Walker, R. G., Webster, A. C., Wilson, A., Wong, G. and Craig, J. C. (2014). Research priorities in chronic kidney disease: a priority setting partnership. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25-27 August 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Research priorities in chronic kidney disease: a priority setting partnership

2014

Journal Article

Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network

Morrish, A.T., Hawley, C.M., Johnson, D.W., Badve, S.V., Perkovic, V., Reidlinger, D.M. and Cass, A. (2014). Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network. Kidney International, 85 (1), 23-30. doi: 10.1038/ki.2013.391

Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network

2014

Conference Publication

Feasibility and construct validity of a frailty index for patients with chronic kidney disease

Smith, Morgan, Peel, Nancye, Dawson, Blake, Lambat, Zahed, Bak, Melissa, Johnson, David W. and Hubbard, Ruth E. (2014). Feasibility and construct validity of a frailty index for patients with chronic kidney disease. Australian and New Zealand Society for Geriatric Medicine Annual Scientific Meeting, Melbourne, VIC, Australia, 28–30 May 2014. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/ajag.12177

Feasibility and construct validity of a frailty index for patients with chronic kidney disease

2014

Conference Publication

Progression to chronic kidney disease after acute kidney injury involves prolonged oxidative stress and persistent tubular metabolic alterations

Small, D. M., Sanchez, W. Y., Roy, S. F., Morais, C., Johnson, D. W. and Gobe, G. C. (2014). Progression to chronic kidney disease after acute kidney injury involves prolonged oxidative stress and persistent tubular metabolic alterations. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, VIC, Australia, 25–27 August 2014. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301

Progression to chronic kidney disease after acute kidney injury involves prolonged oxidative stress and persistent tubular metabolic alterations

2014

Conference Publication

Microbiological results of the Honeypot Study - Secondary analysis of a randomised, controlled trial of exit site application of Medihoney for the prevention of catheter-associated infections in Pd patients

Zhang, L., Badve, S. V., Pascoe, E. M., Beller, E., Cass, A., Clark, C., De Zoysa, J., Isbel, N. M., Mctaggart, S., Morrish, A. T., Playford, E. G., Scaria, A., Snelling, P., Vergara, L. A., Hawley, C. M., Johnson, D. W. and Honeypot Study Collaborative Group (2014). Microbiological results of the Honeypot Study - Secondary analysis of a randomised, controlled trial of exit site application of Medihoney for the prevention of catheter-associated infections in Pd patients. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301

Microbiological results of the Honeypot Study - Secondary analysis of a randomised, controlled trial of exit site application of Medihoney for the prevention of catheter-associated infections in Pd patients

2014

Journal Article

Peritoneal dialysis-related peritonitis: Towards improving evidence, practices, and outcomes

Cho, Yeoungjee and Johnson, David W. (2014). Peritoneal dialysis-related peritonitis: Towards improving evidence, practices, and outcomes. American Journal of Kidney Diseases, 64 (2), 278-289. doi: 10.1053/j.ajkd.2014.02.025

Peritoneal dialysis-related peritonitis: Towards improving evidence, practices, and outcomes

2014

Conference Publication

Tacrolimus Toxicity From Nilutamide Co-Administration: a Case Report

Kennard, A., Johnson, D. and Hawley, C. (2014). Tacrolimus Toxicity From Nilutamide Co-Administration: a Case Report. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. Hoboken, NJ United States: Wiley-Blackwell.

Tacrolimus Toxicity From Nilutamide Co-Administration: a Case Report

2014

Conference Publication

Assessment of Current Practice and Barriers to Antimicrobial Prophylaxis in Peritoneal Dialysis Patients

Campbell, D. J., Brown, F., Craig, J., Gallagher, M., Johnson, D. W., Kirkland, G., Kumar, S. K., Lim, W. H., Ranganathan, D., Saweirs, W., Sud, K., Toussaint, N. D., Walker, R. G., Yehia, M. and Mudge, D. W. (2014). Assessment of Current Practice and Barriers to Antimicrobial Prophylaxis in Peritoneal Dialysis Patients. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, VIC Australia, 25 - 27 August 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301

Assessment of Current Practice and Barriers to Antimicrobial Prophylaxis in Peritoneal Dialysis Patients

2014

Conference Publication

A Randomized, Placebo-Controlled Trial of Pentoxifylline On Erythropoiesis Stimulating Agent Resistance in Anaemic Patients with Chronic Kidney Disease - the Hero Trial

Johnson, D. W., Pascoe, E., Badve, S. V., Dalziel, K., Cass, A., Clarke, P., Ferrari, P., Mcdonald, S. P., Morrish, A. T., Pedagogos, E., Perkovic, V., Scaria, A., Walker, R., Vergara, L. A. and Hawley, C. M. (2014). A Randomized, Placebo-Controlled Trial of Pentoxifylline On Erythropoiesis Stimulating Agent Resistance in Anaemic Patients with Chronic Kidney Disease - the Hero Trial. Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/nep.12301

A Randomized, Placebo-Controlled Trial of Pentoxifylline On Erythropoiesis Stimulating Agent Resistance in Anaemic Patients with Chronic Kidney Disease - the Hero Trial